Skip to main content

Advertisement

SpringerLink
Log in

Effects of interleukin-1, tumor necrosis factor-β, and forskolin on tissue plasminogen activator activity in human osteoblastic osteosarcoma cells

  • Clinical Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

The effects of interleukin-1 (IL-1), forskolin, and tumor necrosis factor β (TNF-β) on tissue plasminogen activator (t-PA) activity were studied in the human osteoblastic osteosarcoma cell line, G292. t-PA activity was measured in the cell media using the chromogenic substrate, S-2251. After a 24 hour incubation period, IL-1 increased t-PA in a dose-dependent manner. The effect of IL-1 at 10.0 U/ml was partially inhibited in the presence of indomethacin. Forskolin (1.0 μM) increased t-PA activity after 24 hours with the effects of combined treatment of IL-1 (1.0 U/ml, 10.0 U/ml) and forskolin being apparently additive in nature. TNF-β (10-8–10-7 M) also produced increased t-PA activity in the cell medial after a 24 hour incubation period. These results suggest that the cytokines, IL-1 and TNF-β, can increase t-PA activity in G292 cells and that there is both a cAMP-dependent as well as a cAMP-independent pathway involved in the regulation of this osteoblastic cell function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Saksela O (1985) Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 283:35–65

    Google Scholar 

  2. Robinson RM, Taylor RE, Birkedal-Hansen (1984) Evidence for an extracellular plasmin-dependent proteolytic system in mineralizing matrices. Calcif Tissue Int 36:31–38

    Google Scholar 

  3. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Neilsen S, Skriver L (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139–266

    Google Scholar 

  4. Werb Z, Mainardi MD, Vater CA, Harris ED Jr (1977) Endogenous activation of latent collagenase by rheumatoid synovial cells. N Engl J Med 296:1017–1029

    Google Scholar 

  5. Allan EH, Hamilton JA, Medcalf RL, Kubota M, Martin TJ (1986) Cyclic AMP-dependent and-independent effects on tissue type plasminogen activator activity in osteogenic sarcoma cells: evidence from phosphodiesterase inhibition and parathyroid hormone antagonists. Biochim Biophys Acta 888:199–207

    Google Scholar 

  6. Pfeilschifter J, Erdmann J, Schmidt W, Naumann A, Minne HW, Ziegler R (1990) Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors. Endocrinology 126:703–711

    Google Scholar 

  7. Partridge NC, Kemp BE, Veroni MC, Martin TJ (1981) Activation of cyclic AMP-dependent protein kinase in normal and malignant bone cells by parathyroid hormone, prostaglandin E2 and prostacyclin. Endocrinology 108:220–225

    Google Scholar 

  8. Hamilton JA, Lingelbach S, Partridge NC, Martin TJ (1985) Regulation of plasminogen activator production by bone resorbing hormones in normal and malignant osteoblasts. Endocrinology 116:2186–2191

    Google Scholar 

  9. Strickland S, Beers WH (1976) Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides and prostaglandins. J Biol Chem 254:5694–5702

    Google Scholar 

  10. Dayer JM, Vassalli JD, Bobbitt JL, Hull RN, Reich E, Krane SM (1981) Calcitonin stimulates plasminogen activator in porcine renal tubular cells. J Cell Biol 91:195–200

    Google Scholar 

  11. Strickland S, Smith KK, Marotti KR (1980) Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21:347–355

    Google Scholar 

  12. Gowen M, Wood D, Ihrie E, Mcguire M, Russell R (1983) An interleukin-1-like factor stimulates bone resorption in vitro. Nature 306:378–380

    Google Scholar 

  13. Charon JA, Luger TA, Mergenhagen SE, Oppenheim JJ (1982) Increased thymocyte-activating factor in human gingival fluid during gingival inflammation. Infect Immun 38:1190–1195

    Google Scholar 

  14. Leizer T, Clarris BJ, Ash PE, Van Damme J, Saklatvala J, Hamilton JA (1987) Interleukin-1 beta and interleukin-1 alpha stimulate the plasminogen activator activity and prostaglandin E2 levels of human synovial cells. Arthritis Rheum 30:562–566

    Google Scholar 

  15. Mochan E, Uhl J, Newton R (1986) Evidence that interleukin-1 induction of synovial cell plasminogen activator is mediated via prostaglandin E2 cAMP. Arthritis Rheum 29:1078–1084

    Google Scholar 

  16. Mochan E, Armor L, Sporer R (1988) Interleukin-1 stimulation of plasminogen activator production in cultured gingival fibroblasts. J Periodont Res 23:28–32

    Google Scholar 

  17. Campbell IK, Piccoli DS, Roberts MJ, Muirden KD, Hamilton JA (1990) Effects of tumor necrosis factors and β on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum 33:542–552

    Google Scholar 

  18. Evans DB, Bunning RAD, Russell RGG (1990) The effects of recombinant interleukin-1 on cellular proliferation and the production of prostaglandin E2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone. Biochem Biophys Res Commun 166:208–216

    Google Scholar 

  19. Tatakis DN, Schneeberger G, Dziak R (1988) Recombinant interleukin-1 stimulates prostaglandin E2 production by osteoblastic cells: synergy with parathyroid hormone. Calcif Tissue Int 42:358–362

    Google Scholar 

  20. Shapiro S, Tatakis DN, Dziak R (1990) Effects of tumor necrosis factor alpha on parathyroid hormone-induced increases in osteoblastic cell cyclic AMP. Calcif Tissue Int 46:60–62

    Google Scholar 

  21. Tatakis DN, Schneeberger G, Dziak R (1991) Recombinant interleukin-1 stimulates prostaglandin E2 production by osteoblastic cells: role of calcium, calmodulin and cAMP. Lymphokine Res 10:95–99

    Google Scholar 

  22. Shupnik MA, Tashjian AH Jr (1982) Epidermal growth factor and phorbol ester actions on human osteosarcoma cells: characterization of responsive and non-responsive lines. J Biol Chem 257:12161–12168

    Google Scholar 

  23. Rodan SB, Imai Y, Thied MA, Wesolowoski G, Thompson D, Bar-Shavit Z, Shull S, Mann K, Rodan GA (1987) Cancer Res 47:4961–4966

    Google Scholar 

  24. Nilsson K, Rosen S, Friberger P (1987) A new kit for the determination of tissue plasminogen activator and its inhibitor in blood. Fibrinolysis 1:163–168

    Google Scholar 

  25. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM (1987) Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 138:1464–1468

    Google Scholar 

  26. Heath JK, Saklatvala J, Meikle MC, Atkinson SJ, Reynolds JJ (1985) Pig interleukin-1 (catabolin) is a potent stimulator of bone resorption in vitro. Calcif Tissue Int 37:95–97

    Google Scholar 

  27. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJ, Mundy GR (1989) Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142–1150

    Google Scholar 

  28. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 319:516–518

    Google Scholar 

  29. Tatakis DN, Dziak R (1989) Recombinant human lymphotoxin effects on osteoblastic cells. Biochem Biophys Res Commun 162:435–440

    Google Scholar 

  30. Chambers TJ, Darby JA, Fuller K (1985) Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tissue Res 241:671–677

    Google Scholar 

  31. Canalis E (1986) Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvaria. Endocrinology 118:74–81

    Google Scholar 

  32. Stashenko P, Dewhirst F, Rooney ML, Desjardins LA, Healey JD (1987) Interleukin-1β is a potent inhibitor of bone formation in vitro. J Bone Min Res 2:559–565

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral Biology, School of Dental Medicine, State University of New York at Buffalo, 14214, Buffalo, New York, U.S.A.

    A. C. Kohl, D. N. Tatakis, C. Hansen & R. Dziak

Authors
  1. A. C. Kohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. N. Tatakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Dziak
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kohl, A.C., Tatakis, D.N., Hansen, C. et al. Effects of interleukin-1, tumor necrosis factor-β, and forskolin on tissue plasminogen activator activity in human osteoblastic osteosarcoma cells. Calcif Tissue Int 50, 129–133 (1992). https://doi.org/10.1007/BF00298789

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00298789

Key words

Search

Navigation